Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.

One hope to maintain the benefits of antiviral therapy against the human immunodeficiency virus type 1 (HIV-1), despite the development of resistance, is the possibility that resistant variants will show decreased viral fitness. To study this possibility, HIV-1 variants showing high-level resistance...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Croteau, G, Doyon, L, Thibeault, D, McKercher, G, Pilote, L, Lamarre, D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191160/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8995629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.2.1089-1096.1997
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!